#ExpertAnswers: Christian Schnell on Pharmacology Studies in Oncology Research
Airdate: Wednesday, June 16, 2021 Season: 8 Episode: 36
Guests: Christian Schnell, Tsung Tan
In this episode of #ExpertAnswers join Christian Schnell, Associate Director of Oncology at Novartis in Basel, as he answers questions from a recent webinar on accurate PK-PD assessment and corresponding antitumor activity in pharmacology studies for oncology research.
For more information, to watch the webinar, or to download a copy of the full Q&A Report, click here.
Associated Webinar: Compound Delivery, PK-PD, & Validation Studies in Oncology Research
Similar Podcasts
Industry Insights with Crown Bioscience: Analyzing the Suppressive TME in In Vitro Based Assays
Nataliia Beztsinna and Marten Hornsveld from Crown Bioscience talk about native and reconstituted TME assays, how they can help in the preparation for clinical trials, and what kinds of therapies in development would benefit the most from this kind of testing.
#ExpertAnswers: Marrit Putker, Saskia De Man, and Pirouz Daftarian on T Cell-Directed Immunotherapy
Marrit Putker, Saskia De Man, and Pirouz Daftarian from Crown Bioscience discuss T cell-directed immunotherapy on the cancer-immunity cycle, including mechanisms and targets capable of modulating and enhancing T cell activity and the application of methods and models including organoids and high content imaging.
Industry Insights with Crown Bioscience: Targeting T Cells Within the Cancer Immunity Cycle
Saskia De Man, Marrit Putker, and Pirouz Daftarian from Crown Bioscience discuss the impact of T cell-directed immunotherapy on the cancer-immunity cycle.
Related Content
Colorectal Tumor Imaging
Join Jessica Freeling as she discusses several models of colorectal cancer in mice and their imaging methods.
Contrast-Enhanced Bladder Tumor Imaging
Join Massimo Alfano, PhD, as he discusses a novel platform for bladder tumor imaging.
Pancreatic Tumor and Therapy Monitoring
Join Dr. Srivalleesha Mallidi as she discusses advances in pancreatic cancer therapies using ultrasound-guided photoacoustic imaging.